Aurinia Pharmaceuticals Inc.
Recent Filings
All 581 filings →| Form | Description | Date |
|---|---|---|
| SCHEDULE 13D/A | — | Mar 25, 2026 |
| 8-K | 8-K | Mar 23, 2026 |
| 4 | FORM 4 | Mar 10, 2026 |
| 4 | — | Mar 3, 2026 |
| SCHEDULE 13D/A | — | Mar 3, 2026 |
| 4 | FORM 4 | Mar 3, 2026 |
| 4 | FORM 4 | Mar 3, 2026 |
| 4 | FORM 4 | Mar 3, 2026 |
| 4 | FORM 4 | Mar 3, 2026 |
| 4 | FORM 4 | Mar 3, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| TANG KEVIN | — | Purchase | 100,000 @ $11.34 | 11,129,500 | Aug 1, 2025 |
| Keenan Greg | Chief Medical Officer | Sale | 20,000 @ $10.50 | 133,484 | Aug 1, 2025 |
| Keenan Greg | Chief Medical Officer | Sale | 8,305 @ $8.23 | 153,484 | Mar 7, 2025 |
| Miller Joseph M | Chief Financial Officer | Award / Grant | 114,711 | 695,374 | Mar 4, 2025 |
| Robertson Stephen P. | EVP, General Counsel | Award / Grant | 84,106 | 529,349 | Mar 4, 2025 |
| Greenleaf Peter | Chief Executive Officer | Sale | 164,947 @ $7.92 | 1,788,945 | Mar 3, 2025 |
| Keenan Greg | Chief Medical Officer | Award / Grant | 62,583 | 174,028 | Mar 3, 2025 |
| Donley Matthew Maxwell | Chief Operating Officer | Sale | 58,991 @ $7.92 | 680,465 | Mar 3, 2025 |
| TANG KEVIN | — | Purchase | 351,962 @ $8.02 | 9,281,462 | Mar 3, 2025 |
| TANG KEVIN | — | Purchase | 500,000 @ $9.09 | 8,429,500 | Dec 5, 2024 |